A citation-based method for searching scientific literature

M Strupp, R Kalla, M Dichgans, T Freilinger, S Glasauer, T Brandt. Neurology 2004
Times Cited: 145



Michael Strupp, Andreas Zwergal, Thomas Brandt. Neurotherapeutics 2007
Times Cited: 96




List of shared articles



Times cited



Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial.
Carolin Muth, Julian Teufel, Ludger Schöls, Matthis Synofzik, Christiana Franke, Dagmar Timmann, Ulrich Mansmann, Michael Strupp. Neurol Clin Pract 2021
1

The neurological update: therapies for cerebellar ataxias in 2020.
J Gandini, Mario Manto, T Bremova-Ertl, K Feil, M Strupp. J Neurol 2020
10

Advances in pharmacotherapy of vestibular and ocular motor disorders.
Andreas Zwergal, Michael Strupp, Thomas Brandt. Expert Opin Pharmacother 2019
3

Aminopyridines for the treatment of neurologic disorders.
Michael Strupp, Julian Teufel, Andreas Zwergal, Roman Schniepp, Kamran Khodakhah, Katharina Feil. Neurol Clin Pract 2017
29

Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: translational and back-translational research.
Michael Strupp, Andreas Zwergal, Katharina Feil, Tatiana Bremova, Thomas Brandt. Ann N Y Acad Sci 2015
22

[Pharmacotherapy of Vestibular Disorders, Nystagmus and Cerebellar Disorders].
K Feil, N Böttcher, O Kremmyda, C Muth, J Teufel, A Zwergal, T Brandt, M Strupp. Fortschr Neurol Psychiatr 2015
2

[Peripheral, central and functional vertigo syndromes].
M Strupp, M Dieterich, A Zwergal, T Brandt. Nervenarzt 2015
4

Introducing treatment strategy for cerebellar ataxia in mutant med mice: combination of acetazolamide and 4-aminopyridine.
Samira Abbasi, Ataollah Abbasi, Yashar Sarbaz. Comput Methods Programs Biomed 2014
4

Therapies for ataxias.
Laurence Martineau, Anne Noreau, Nicolas Dupré. Curr Treat Options Neurol 2014
1

The first knockin mouse model of episodic ataxia type 2.
Samuel J Rose, Lisa H Kriener, Ann K Heinzer, Xueliang Fan, Robert S Raike, Arn M J M van den Maagdenberg, Ellen J Hess. Exp Neurol 2014
13

Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.
Sanjeev Rajakulendran, Diego Kaski, Michael G Hanna. Nat Rev Neurol 2012
86

Which medication do I need to manage dizzy patients?
Doreen Huppert, Michael Strupp, Harald Mückter, Thomas Brandt. Acta Otolaryngol 2011
20

Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.
Michael Strupp, Matthew J Thurtell, Aasef G Shaikh, Thomas Brandt, David S Zee, R John Leigh. J Neurol 2011
62

[Hereditary episodic ataxia].
F Riant, K Vahedi, E Tournier-Lasserve. Rev Neurol (Paris) 2011
9

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
111

Vertigo and dizziness in childhood - update on diagnosis and treatment.
K Jahn, T Langhagen, A S Schroeder, F Heinen. Neuropediatrics 2011
36

KCa channels as therapeutic targets in episodic ataxia type-2.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
72

The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
113


In vivo 4-aminopyridine treatment alters the neurotoxin 3-acetylpyridine-induced plastic changes in intrinsic electrophysiological properties of rat cerebellar Purkinje neurones.
Iran Goudarzi, Mohammadreza Kaffashian, Mohammad Shabani, Hashem Haghdoost-Yazdi, Gila Behzadi, Mahyar Janahmadi. Eur J Pharmacol 2010
13

Co-treatment with riluzole, a neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurones of rats: behavioural and electrophysiological evidence.
Mahyar Janahmadi, Iran Goudarzi, Mohammad Reza Kaffashian, Gila Behzadi, Yaqub Fathollahi, Sohrab Hajizadeh. Neurotoxicology 2009
23